(Q36760023)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361214%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

review article

1 reference

title

Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361214%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361214%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Aerts JL

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361214%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Thielemans K

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361214%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

22 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361214%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361214%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361214%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

847-862

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361214%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361214%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302947

27 December 2019

exact match

0 references

cites work

Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentiviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

Fully functional memory CD8 T cells in the absence of CD4 T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

Sp1 binds two sites in the CD11c promoter in vivo specifically in myeloid cells and cooperates with AP1 to activate transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

Human tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

T cell defined tumor antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

CD4+ Tregs and immune control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Mass determination of rous sarcoma virus virions by scanning transmission electron microscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Kinetics of retrovirus production and decay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Integration of murine leukemia virus DNA depends on mitosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

A third-generation lentivirus vector with a conditional packaging system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Development of a self-inactivating lentivirus vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Promoter interference mediated by the U3 region in early-generation HIV-1-derived lentivirus vectors can influence detection of transgene expression in a cell-type and species-specific manner.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

No false start for novel pseudotyped vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Semliki Forest virus core protein fragmentation: its possible role in nucleocapsid disassembly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Development of multigene and regulated lentivirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Lentiviral vectors: regulated gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

A new-generation stable inducible packaging cell line for lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Prostate-specific targeting using PSA promoter-based lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Regression of prostate cancer xenografts by a lentiviral vector specifically expressing diphtheria toxin A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Production of retrovirus and adenovirus vectors for gene therapy: a comparative study using microcarrier and stationary cell culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

A stable system for the high-titer production of multiply attenuated lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus-based lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Continuous high-titer HIV-1 vector production.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

The cytotoxicity of human immunodeficiency virus type 1 Rev: implications for its interaction with the nucleolar protein B23

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Optimized large-scale production of high titer lentivirus vector pseudotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Concentration of viral vectors by co-precipitation with calcium phosphate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Lentivirus vector purification using anion exchange HPLC leads to improved gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Quantitative determination of lentiviral vector particle numbers by real-time PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction as a Method for Determining Lentiviral Vector Titers and Measuring Transgene Expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Factors influencing the titer and infectivity of lentiviral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Lentivirally transduced dendritic cells as a tool for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Efficient lentiviral transduction of human cord blood CD34(+) cells followed by their expansion and differentiation into dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Rapid and efficient generation of lentivirally gene-modified dendritic cells from DC progenitors with bone marrow stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Transduction of dendritic cells by antigen-encoding lentiviral vectors permits antigen processing and MHC class I-dependent presentation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Induction of therapeutic antitumor immunity by in vivo administration of a lentiviral vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Efficient induction of tumor antigen-specific CD8+ memory T cells by recombinant lentivectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Escape of human immunodeficiency virus from immune control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

How cells respond to interferons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

PKR and eIF2alpha: integration of kinase dimerization, activation, and substrate docking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Innate immune recognition of viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Dendritic-cell control of pathogen-driven T-cell polarization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Recognition of cytosolic DNA activates an IRF3-dependent innate immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Identification and expression of mouse Langerin (CD207) in dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Targeted retroviral transduction of c-kit+ hematopoietic cells using novel ligand display technology.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Growth factor displayed on the surface of retroviral particles without manipulation of envelope proteins is biologically active and can enhance transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Targeting lentiviral vectors to specific cell types in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Naturally occurring antibodies devoid of light chains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Gene therapy insertional mutagenesis insights

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Virology. Picking the right spot.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Insertional oncogenesis in gene therapy: how much of a risk?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

HIV-1 integration in the human genome favors active genes and local hotspots

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Effective gene therapy with nonintegrating lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Highly efficient endogenous human gene correction using designed zinc-finger nucleases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

A phage integrase directs efficient site-specific integration in human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

In vivo correction of murine hereditary tyrosinemia type I by phiC31 integrase-mediated gene delivery.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Novel integrase-defective lentiviral episomal vectors for gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Correction of cardiac abnormalities in fabry mice by direct intraventricular injection of a recombinant lentiviral vector that engineers expression of alpha-galactosidase A.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

In Vivo Transduction by Intravenous Injection of a Lentiviral Vector Expressing Human ADA into Neonatal ADA Gene Knockout Mice: A Novel Form of Enzyme Replacement Therapy for ADA Deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Limited transgene immune response and long-term expression of human alpha-L-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Local gene transfer to calcified tissue cells using prolonged infusion of a lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Lentiviral gp34/OX40L gene transfer into dendritic cells facilitates alloreactive CD4+ T-cell response in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Lentiviral vectors: optimization of packaging, transduction and gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Transduction Patterns of Pseudotyped Lentiviral Vectors in the Nervous System

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Preferential transduction of human hepatocytes with lentiviral vectors pseudotyped by Sendai virus F protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Jaagsiekte sheep retrovirus envelope efficiently pseudotypes human immunodeficiency virus type 1-based lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Gene transfer to respiratory epithelia with lentivirus pseudotyped with Jaagsiekte sheep retrovirus envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302947

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302947

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361214%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference